Our trust is at the heart of what we do

Psychedelics are a powerful tool. In the shadow of the opioid crisis, development of powerful medicines like these must be done with the utmost care. Having a broad spectrum of stakeholders empowers us to steward these medicines responsibly, to the direct benefit of the communities and shareholders we serve.

Whether it be through the Journey Reciprocity Trust, or priority access to our new treatments, Journey Colab seeks to rebuild the foundation of the modern addiction industry.

Our work with these stakeholders not only provides rich expertise to improve the quality of the therapies we produce, but also opens an opportunity for us to create a vibrant "healing economy" that includes the therapy and community support that are critical for successful treatment.

We are dedicated to benefiting the practices of medical organizations seeking to advance psychedelic and mental health care services, especially to disadvantaged communities.

Journey Colab believes that consultation with community stakeholders is essential to building an integrated treatment program for addiction.

Learn more about our consultation process in our white paper and our ongoing dialogue on reciprocity and consultation